Proehl Investment Ventures LLC
First SEC filing: Aug. 12, 2021 · Latest: Jan. 8, 2026
Insider at
Insider transactions
Price change vs the latest weekly close (updated to the current quote in your browser when available), split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 17, 2021 | DRMA | C | 361,147 | · | · | 1,278,464 Direct | +39.37% | Acquired | |
| Aug. 17, 2021 | DRMA | C | 111,951 | · | · | 1,390,415 Direct | +8.76% | Acquired | |
| Aug. 17, 2021 | DRMA | C | 181,585 | · | · | 1,572,000 Direct | +13.06% | Acquired | |
| Aug. 17, 2021 | DRMA | C | 1,247,904 | · | · | 2,819,904 Direct | +79.38% | Acquired | |
| Aug. 17, 2021 | DRMA | C | 85,640 | · | · | 2,905,544 Direct | +3.04% | Acquired | |
| Aug. 17, 2021 | DRMA | C | 2,436,657 | · | · | 0 Direct | -100.00% | Disposed | |
| Aug. 17, 2021 | DRMA | C | 2,295,000 | · | · | 0 Direct | -100.00% | Disposed | |
| Aug. 17, 2021 | DRMA | C | 3,722,500 | · | · | 0 Direct | -100.00% | Disposed | |
| Aug. 17, 2021 | DRMA | C | 25,582,050 | · | · | 0 Direct | -100.00% | Disposed | |
| Aug. 17, 2021 | DRMA | C | 1,755,622 | · | · | 0 Direct | -100.00% | Disposed | |
| Aug. 17, 2021 | DRMA | C | 573,750 | · | · | 0 Direct | -100.00% | Disposed | |
| Aug. 17, 2021 | DRMA | C | 27,987 | · | · | 27,987 Direct | · | Acquired |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 17, 2021 | DRMA | Series 1d Preferred Stock | Common Stock | · | · | 2,436,657 | Disposed |
| Aug. 17, 2021 | DRMA | Series 1a Preferred Stock | Common Stock | · | · | 2,295,000 | Disposed |
| Aug. 17, 2021 | DRMA | Series 1b Preferred Stock | Common Stock | · | · | 3,722,500 | Disposed |
| Aug. 17, 2021 | DRMA | Series 1c Preferred Stock | Common Stock | · | · | 25,582,050 | Disposed |
| Aug. 17, 2021 | DRMA | Series 1 Preferred Stock | Common Stock | · | · | 1,755,622 | Disposed |
| Aug. 17, 2021 | DRMA | Series 1a Warrants | Common Stock | · | March 14, 2026 | 573,750 | Disposed |
| Aug. 17, 2021 | DRMA | Warrant to Purchase Common Stock | Common Stock | $20.50 | March 14, 2026 | 27,987 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 7 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 12, 2021 | DRMA | Common Stock | 917,317 | Direct |
| Aug. 12, 2021 | DRMA | Series 1d Preferred Stock | · | Direct |
| Aug. 12, 2021 | DRMA | Series 1a Preferred Stock | · | Direct |
| Aug. 12, 2021 | DRMA | Series 1b Preferred Stock | · | Direct |
| Aug. 12, 2021 | DRMA | Series 1c Preferred Stock | · | Direct |
| Aug. 12, 2021 | DRMA | Series 1 Preferred Stock | · | Direct |
| Aug. 12, 2021 | DRMA | Series 1a Warrants | · | Direct |